Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticleResearch

Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence

Retrospective cohort study of 30 patients

Joe Dooley, Lianne Gerber-Finn, Irwin Antone, John Guilfoyle, Brittany Blakelock, Jazmyn Balfour-Boehm, Wilma M. Hopman, Naana Jumah and Len Kelly
Canadian Family Physician April 2016; 62 (4) e194-e200;
Joe Dooley
Assistant professors in the Division of Clinical Sciences at the Northern Ontario School of Medicine in Sioux Lookout, Ont, and the Sioux Lookout Meno Ya Win Health Centre (SLMHC).
MD CCFP FCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lianne Gerber-Finn
Assistant professors in the Division of Clinical Sciences at the Northern Ontario School of Medicine in Sioux Lookout, Ont, and the Sioux Lookout Meno Ya Win Health Centre (SLMHC).
MD CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irwin Antone
Assistant professors in the Division of Clinical Sciences at the Northern Ontario School of Medicine in Sioux Lookout, Ont, and the Sioux Lookout Meno Ya Win Health Centre (SLMHC).
MD CCFP FCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Guilfoyle
Assistant professors in the Division of Clinical Sciences at the Northern Ontario School of Medicine in Sioux Lookout, Ont, and the Sioux Lookout Meno Ya Win Health Centre (SLMHC).
MD CCFP FCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Blakelock
Researcher with the SLMHC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jazmyn Balfour-Boehm
Medical student at the Northern Ontario School of Medicine.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilma M. Hopman
Statistician in the Department of Community Health and Epidemiology at Queen’s University in Kingston, Ont.
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naana Jumah
Assistant Professor in the Division of Clinical Science at the Northern Ontario School of Medicine in Thunder Bay, Ont, a clinician researcher with the Thunder Bay Regional Research Institute, and an obstetrician-gynecologist at Thunder Bay Regional Health Centre.
MD DPhil FRCSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Len Kelly
Researcher with the SLMHC.
MD MClSc FCFP FRRM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lkelly@mcmaster.ca
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Maternal characteristics and outcomes

    CHARACTERISTICSA: EXPOSED TO BUPRENORPHINE-NALOXONE (N = 30)B: EXPOSED TO OTHER OPIOIDS (N = 134)P VALUE (A–B)C: NOT EXPOSED TO OPIOIDS (N = 476)P VALUE (A–C)
    Mean (SD) age, y26.1 (4.03)25.4 (4.56).44224.9 (6.17).296
    Mean (SD) gravidity4.4 (2.50)3.9 (2.03).2403.2 (2.22).004
    Mean (SD) time taking buprenorphinenaloxone, wk18.8 (11.20)NANANANA
    Initial mean (SD) dose of buprenorphinenaloxone, mg9.2 (6.20)NANANANA
    Smoker, n (%)25 (83.3)113 (84.3).893229 (48.1)< .001
    Alcohol use, n (%)6 (20.0)32 (23.9).64998 (20.6).938
    Type 2 diabetes, n (%)2 (6.7)3 (2.2).22714 (2.9).244
    Hypertension, n (%)3 (10.0)8 (6.0).42429 (6.1).426
    Hepatitis C, n (%)1 (3.3)7 (5.2)1 (0.2).115
    History of marijuana use, n (%)4 (13.3)49 (36.6).01446 (9.7).514
    Urine positive for THC, n (%)4 (13.3)35 (26.1).13728 (5.9).104
    Gestational diabetes, n (%)3 (10.0)13 (9.7).96042 (8.8).742
    Mean (SD) gestational age, wk38.9 (1.48)38.6 (1.60).34838.9 (1.52)> .999
    Cesarean section, n (%)5 (16.7)35 (26.1).276120 (25.2).293
    Postpartum hemorrhage, n (%)3 (10.0)10 (7.5).70844 (9.2).752
    Mean (SD) LOS, d3.0 (1.63)2.7 (1.71).3821.9 (1.13)< .001
    Out-of-hospital delivery, n (%)1 (3.3)3 (2.2).55810 (2.1).493
    • LOS—length of stay, NA—not applicable, THC—tetrahydrocannabinol.

    • View popup
    Table 2.

    Illicit opioid drug use at delivery

    OPIOID USEWOMEN EXPOSED TO BUPRENORPHINE-NALOXONE (N = 30), N (%)WOMEN EXPOSED TO OTHER OPIOIDS (N = 134), N (%)
    Quit*24 (80.0)49 (36.6)
    Decreased3 (10.0)53 (39.6)
    Increased0 (0.0)1 (0.7)
    No change1 (3.3)23 (17.2)
    Unknown2 (6.7)8 (6.0)
    • ↵* Significantly more women in the group exposed to buprenorphinenaloxone had quit using illicit opioids at delivery (P < .001).

    • View popup
    Table 3.

    Neonatal characteristics and outcomes

    NEONATAL CHARACTERISTICSA: EXPOSED TO BUPRENORPHINE-NALOXONE (N = 30)B: EXPOSED TO OTHER OPIOIDS (N = 134)P VALUE (A–B)C: NOT EXPOSED TO OPIOIDS (N = 476)P VALUE (A–C)
    Preterm (< 37 wk), n (%)1 (3.3)6 (4.5).79919 (4.0).857
    Mean (SD) birth weight, g3569.0 (491.91)3243.7 (557.2).0043531.0 (590.2).730
    Mean (SD) 1-min Apgar score8.8 (0.47)8.7 (1.05).6118.6 (1.1).323
    Mean (SD) 5-min Apgar score9.0 (0.18)8.9 (0.83).5138.9 (0.71).442
    Any NAS score, n (%)6 (20.0)22 (16.4).6370 (0.0)< .001
    NAS score > 7, n (%)0 (0.0)12 (9.0).1260 (0.0)> .999
    Stillbirths, n (%)0 (0.0)1 (0.7)> .9993 (0.6)> .999
    Congenital anomalies, n (%)1 (3.3)0 (0.0).1801 (0.2).115
    Male sex, n (%)15 (50.0)74 (55.2).657243 (51.1).911
    Transfer to tertiary care, n (%)1 (3.3)5 (3.7)> .9999 (1.9).460
    • NAS—neonatal abstinence syndrome.

PreviousNext
Back to top

In this issue

Canadian Family Physician: 62 (4)
Canadian Family Physician
Vol. 62, Issue 4
1 Apr 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
Joe Dooley, Lianne Gerber-Finn, Irwin Antone, John Guilfoyle, Brittany Blakelock, Jazmyn Balfour-Boehm, Wilma M. Hopman, Naana Jumah, Len Kelly
Canadian Family Physician Apr 2016, 62 (4) e194-e200;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
Joe Dooley, Lianne Gerber-Finn, Irwin Antone, John Guilfoyle, Brittany Blakelock, Jazmyn Balfour-Boehm, Wilma M. Hopman, Naana Jumah, Len Kelly
Canadian Family Physician Apr 2016, 62 (4) e194-e200;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Addiction in the family: Two Indigenous families overcoming barriers to opioid agonist therapy
  • Google Scholar

More in this TOC Section

  • Trends colliding
  • Primary care reform in Alberta
  • Administrative burden in primary care
Show more Research

Similar Articles

Subjects

  • Collection française
    • Résumés de recherche

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire